BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 19574674)

  • 1. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
    Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
    Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
    Estrada P; Rojas-Atencio A; Zabala W; Borjas L; Soca L; Urdaneta K; Alvarez-Nava F; Cañizales J; Rojas J; Soto M
    Invest Clin; 2009 Mar; 50(1):55-63. PubMed ID: 19418727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
    Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
    J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
    Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
    Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan.
    Wu CM; Tang R; Wang JY; Changchien CR; Hsieh LL
    Cancer Genet Cytogenet; 2005 Apr; 158(1):55-60. PubMed ID: 15771905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292).
    Wadler S; Bajaj R; Neuberg D; Agarwal V; Haynes H; Benson AB
    Cancer J Sci Am; 1997; 3(5):284-8. PubMed ID: 9327152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations.
    Hiraoka S; Kato J; Tatsukawa M; Harada K; Fujita H; Morikawa T; Shiraha H; Shiratori Y
    Gastroenterology; 2006 Aug; 131(2):379-89. PubMed ID: 16890591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area.
    Sameer AS; ul Rehman S; Pandith AA; Syeed N; Shah ZA; Chowdhri NA; Wani KA; Siddiqi MA
    Saudi J Gastroenterol; 2009; 15(4):244-52. PubMed ID: 19794270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of K-ras mutations in plasma after colorectal tumor resection.
    Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
    Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
    Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
    Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
    Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
    Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
    Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
    Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
    Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutation analysis of K-ras protooncogene in colorectal adenocarcinomas and polyps in Russian patients].
    Amosenko FA; Korchagina EL; Matveeva TI; Vaganov IuE; Vlasov SB; Poltavets NV; Veselov VV; Gar'kavtseva RF; Poliakov AV
    Genetika; 2010 May; 46(5):700-8. PubMed ID: 20583607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer.
    Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P
    Anticancer Res; 2000; 20(3A):1695-701. PubMed ID: 10928094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.